The AURKA-YBX1/hnRNPK complex correlates with poor breast cancer prognosis, and blocking nuclear AURKA shows promise in reversing oncogenic splicing events, highlighting YBX1’s significant role in this process. The gene discussed is HNRNPK; the disease is breast cancer.